AAAAAA
Results: 1-25/35
CLINICAL IMPLICATIONS OF DOSE-DEPENDENT CYTOCHROME-P-450 DRUG-DRUG INTERACTIONS WITH ANTIDEPRESSANTS
Authors:
DEVANE CL
Citation: Cl. Devane, CLINICAL IMPLICATIONS OF DOSE-DEPENDENT CYTOCHROME-P-450 DRUG-DRUG INTERACTIONS WITH ANTIDEPRESSANTS, Human psychopharmacology, 13(5), 1998, pp. 329-336
Authors:
UPADHYAYA HP
DEVANE CL
Citation: Hp. Upadhyaya et Cl. Devane, LACK OF URINARY SIDE-EFFECTS WITH NEFAZODONE AS COMPARED TO OTHER NEWER ANTIDEPRESSANTS, Human psychopharmacology, 13(4), 1998, pp. 297-298
Authors:
MARKOWITZ JS
GILL HS
HUNT NM
MONROE RR
DEVANE CL
Citation: Js. Markowitz et al., LACK OF ANTIDEPRESSANT-CYCLOSPORINE PHARMACOKINETIC INTERACTIONS, Journal of clinical psychopharmacology, 18(1), 1998, pp. 91-93
Authors:
DEVANE CL
HILL M
ANTAL EJ
Citation: Cl. Devane et al., THERAPEUTIC DRUG-MONITORING OF ALPRAZOLAM IN ADOLESCENTS WITH ASTHMA, Therapeutic drug monitoring, 20(3), 1998, pp. 257-260
Authors:
GOODNICK PJ
DOMINGUEZ RA
DEVANE CL
BOWDEN CL
Citation: Pj. Goodnick et al., BUPROPION SLOW-RELEASE RESPONSE IN DEPRESSION - DIAGNOSIS AND BIOCHEMISTRY, Biological psychiatry, 44(7), 1998, pp. 629-632
Authors:
GOODNICK P
PUIG A
DEVANE CL
Citation: P. Goodnick et al., MIRTAZAPINE IN COMBINED MAJOR DEPRESSION AND GENERALIZED ANXIETY DISORDER, Biological psychiatry, 43, 1998, pp. 331-331
Authors:
RISCH SC
MOLLOY M
BATCHELOR M
SPEER A
LEWINE RRJ
DEVANE CL
GEORGE M
Citation: Sc. Risch et al., CSF HVA 5HIAA RATIO IS NORMALLY DISTRIBUTED IN UNMEDICATED AND CLOZAPINE TREATED SCHIZOPHRENICS AS COMPARED WITH NORMAL CONTROLS/, Schizophrenia research, 24(1-2), 1997, pp. 67-67
Authors:
SPEER AM
RISCH SC
HAMNER MB
MOLLOY M
ULMER HG
DEVANE CL
VINCENT DJ
GEORGE MS
Citation: Am. Speer et al., THE EFFECT OF AN ATYPICAL ANTIPSYCHOTIC (RISPERIDONE) ON TEMPORAL-LOBE AND PREFRONTAL CORTEX ACTIVITY IN SCHIZOPHRENIA, Schizophrenia research, 24(1-2), 1997, pp. 173-173
Authors:
EDGE SC
MARKOWITZ JS
DEVANE CL
Citation: Sc. Edge et al., CLOZAPINE DRUG-DRUG INTERACTIONS - A REVIEW OF THE LITERATURE, Human psychopharmacology, 12(1), 1997, pp. 5-20
Authors:
DEVANE CL
Citation: Cl. Devane, THE PLACE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENTOF PANIC DISORDER, Pharmacotherapy, 17(2), 1997, pp. 282-292
Authors:
GILL HS
DEVANE CL
RISCH SC
Citation: Hs. Gill et al., EXTRAPYRAMIDAL SYMPTOMS ASSOCIATED WITH CYCLIC ANTIDEPRESSANT TREATMENT - A REVIEW OF THE LITERATURE AND CONSOLIDATING HYPOTHESES, Journal of clinical psychopharmacology, 17(5), 1997, pp. 377-389
Authors:
DEVANE CL
GILL HS
MARKOWITZ JS
CARSON WH
Citation: Cl. Devane et al., AWARENESS OF POTENTIAL-DRUG INTERACTIONS MAY AID AVOIDANCE, Therapeutic drug monitoring, 19(3), 1997, pp. 366-367
Authors:
DEVANE CL
GILL HS
Citation: Cl. Devane et Hs. Gill, CLINICAL PHARMACOKINETICS OF FLUVOXAMINE - APPLICATIONS TO DOSAGE REGIMEN DESIGN, The Journal of clinical psychiatry, 58, 1997, pp. 7-14
Authors:
DEVANE CL
MARKOWITZ JS
HARDESTY SJ
MUNDY S
GILL HS
Citation: Cl. Devane et al., FLUVOXAMINE-INDUCED THEOPHYLLINE TOXICITY, The American journal of psychiatry, 154(9), 1997, pp. 1317-1318
Authors:
MARKOWITZ JS
GILL HS
DEVANE CL
MINTZER JE
Citation: Js. Markowitz et al., FLUOROQUINOLONE INHIBITION OF CLOZAPINE METABOLISM, The American journal of psychiatry, 154(6), 1997, pp. 881-881
Authors:
DEVANE CL
Citation: Cl. Devane, RETHINKING TREATMENT TERMINOLOGY, The American journal of psychiatry, 154(5), 1997, pp. 717-717
Authors:
COHEN LJ
DEVANE CL
Citation: Lj. Cohen et Cl. Devane, CLINICAL IMPLICATIONS OF ANTIDEPRESSANT PHARMACOKINETIC AND PHARMACOGENETICS, The Annals of pharmacotherapy, 30(12), 1996, pp. 1471-1480
Authors:
MARKOWITZ JS
GILL HS
LAVIA M
BREWERTON TD
DEVANE CL
Citation: Js. Markowitz et al., FLUVOXAMINE-CLOZAPINE DOSE-DEPENDENT INTERACTION, Canadian journal of psychiatry, 41(10), 1996, pp. 670-671
Authors:
BYERLY MJ
DEVANE CL
Citation: Mj. Byerly et Cl. Devane, PHARMACOKINETICS OF CLOZAPINE AND RISPERIDONE - A REVIEW OF RECENT LITERATURE, Journal of clinical psychopharmacology, 16(2), 1996, pp. 177-187
Authors:
DEVANE CL
Citation: Cl. Devane, DRUG-DRUG INTERACTIONS - REPLY, The Journal of clinical psychiatry, 57(5), 1996, pp. 225-227
Authors:
DEVANE CL
SALLEE FR
Citation: Cl. Devane et Fr. Sallee, SEROTONIN SELECTIVE REUPTAKE INHIBITORS IN CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY - A REVIEW OF PUBLISHED EXPERIENCE, The Journal of clinical psychiatry, 57(2), 1996, pp. 55-66
Authors:
NEMEROFF CB
DEVANE CL
POLLOCK BG
Citation: Cb. Nemeroff et al., NEWER ANTIDEPRESSANTS AND THE CYTOCHROME-P450 SYSTEM, The American journal of psychiatry, 153(3), 1996, pp. 311-320
Authors:
NEMEROFF CB
DEVANE CL
POLLOCK BG
Citation: Cb. Nemeroff et al., EFFECTS OF ANTIDEPRESSANTS ON THE CYTOCHROME-P450 SYSTEM - REPLY, The American journal of psychiatry, 153(12), 1996, pp. 1656-1657
Authors:
DEVANE CL
Citation: Cl. Devane, PHARMACOKINETICS OF THE NEWER ANTIDEPRESSANTS - REPLY, The American journal of medicine, 100(1), 1996, pp. 120-121
Authors:
DEVANE CL
Citation: Cl. Devane, BRIEF COMPARISON OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE TRADITIONAL AND NEWER ANTIPSYCHOTIC-DRUGS, American journal of health-system pharmacy, 52(3), 1995, pp. 15-18